M. A. Al-Omar
Department of Pharmaceutical Chemistry, College of Pharmacy,
P.O. Box 2457, King Saud University, Riyadh 11451, Saudi Arabia
S. T. Al-Rashood
Department of Pharmaceutical Chemistry, College of Pharmacy,
P.O. Box 2457, King Saud University, Riyadh 11451, Saudi Arabia
H. I. El-Subbagh
Department of Pharmaceutical Chemistry, College of Pharmacy,
P.O. Box 2457, King Saud University, Riyadh 11451, Saudi Arabia
S. G. Abdel Hamide
Department of Pharmaceutical Chemistry, College of Pharmacy,
P.O. Box 2457, King Saud University, Riyadh 11451, Saudi Arabia
ABSTRACT
Aldehyde oxidase and xanthine oxidase are molybdenum-containing enzymes distributed throughout animal kingdom. Aldehyde oxidase has a wide range of substrates including aldehydes and N-heterocycles while xanthine oxidase involves in oxidation of purine analogues to corresponding uric acid. In addition to cytochrome P450 isoenzymes, molybdenum hydroxylases are major defense mechanism for the removal of drugs/xenobiotics from the body. Fifty quinazoline derivatives have been synthesized and characterized by NMR infrared, mass spectrum and elementary analyses. These substituted quinazolines have been examined for their interaction with mol ybdenum hydroxylases and found to be weak inhibitor. They inhibit both enzymes in a competitive pattern with inhibitor constants (Ki) values ranging from 90-1200 μM. The relationship between Ki and relative lipophilicity of quinazolines, as inhibitors of molybdenum hydroxylase enzymes, has been compared. The specific-site of interaction and inhibitory potency of quinazolines on molybdenum hydroxylase have been discussed in this study.
PDF References Citation
How to cite this article
M. A. Al-Omar, S. T. Al-Rashood, H. I. El-Subbagh and S. G. Abdel Hamide, 2005. Interaction of 2-thio-4-oxo-quinazoline Derivatives with Guinea Pig Liver Molybdenum
Hydroxylases, Xanthine Oxidase and Aldehyde Oxidase. Journal of Biological Sciences, 5: 370-378.
DOI: 10.3923/jbs.2005.370.378
URL: https://scialert.net/abstract/?doi=jbs.2005.370.378
DOI: 10.3923/jbs.2005.370.378
URL: https://scialert.net/abstract/?doi=jbs.2005.370.378
REFERENCES
- Al-Omar, M.A., H.I. El-Subbagh, C. Beedham and J.A. Smith, 2005. Role of molybdenum hydroxylases in diseases. Saudi. Pharm. J., 13: 1-13.
Direct Link - Pritsos, C.A., 2000. Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem. Biol. Int., 129: 195-208.
Direct Link - Calzi, M.L., C. Raviolo, E. Ghibaudi, D. Salmona and G. Cazzaniga et al., 1995. Purification, cDNA cloning and tissue distribution of bovine liver aldehyde oxidase. J. Biol. Chem., 270: 31037-31045.
Direct Link - Castro G.D., A.M.A. Delgado de Layno, M.H. Costantini and J.A. Castro, 2001. Cytosolic xanthine oxidoreductase mediated bioactivation of ethanol to acetaldehyde and free radicals in rat breast tissue: Its potential role in alcohol-promoted mammary cancer. Toxicology, 160: 11-18.
Direct Link - Wright, R.M., J.L. McManaman and J.E. Repine, 1999. Alcohol-induced breast cancer: A proposed mechanism. Free Radic. Biol. Med., 26: 348-354.
Direct Link - Schofield, P.C., I.G.C. Robertson and J.W. Paxton, 2000. Inter-species variation in the metabolism and inhibition of n-[(2-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase. Biochem. Pharmacol., 59: 161-165.
Direct Link - Sielecki, T.M., T.L. Johnson, J. Liu, J.K. Muckelbauer and R.H. Grafstrom et al., 2001. Quinazolines as cyclin dependent kinase inhibitors. Bioorg. Med. Chem. Lett., 11: 1157-1160.
Direct Link - Ghafourian, T. and M.R. Rashidi, 2001. Quantitative study of structural requirement of phthalazine/quinazoline derivatives for interaction with human liver aldehyde oxidase. Chem. Pharm. Bul., 49: 1066-1071.
Direct Link - Massey, V., H. Komai, G. Palmer and G.B. Elion, 1970. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo [3, 4-d] pyrimidines. J. Biol. Chem., 245: 2837-2844.
Direct Link - Johns, D.G., 1967. Human liver aldehyde oxidase: Differential inhibition of oxidation of charged and uncharged substrates. J. Clin. Invest., 46: 1492-1505.
Direct Link